Palvella Therapeutics, Inc. Share Price Today: Live Updates & Key Insights
Palvella Therapeutics, Inc. share price today is $112.87, up -1.24%. The stock opened at $114.835 against the previous close of $113.91, with an intraday high of $114.835 and low of $110.89.
Palvella Therapeutics, Inc. Share Price Chart
Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. Share Price Performance
Palvella Therapeutics, Inc. Institutional Holdings
Palvella Therapeutics, Inc. Market Status
Palvella Therapeutics, Inc. Fundamentals
Market Cap 1600.83 M
PB Ratio 41.8257
PE Ratio 0.0
Enterprise Value 1557.32 M
Total Assets 88.23 M
Volume 374637
Palvella Therapeutics, Inc. Company Financials
About Palvella Therapeutics, Inc. & investment objective
Company Information Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN 3.9% rapamycin anhydrous gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of other mTOR-driven skin diseases. The company is based in Wayne, Pennsylvania
Organisation Biotechnology
Employees 14
Industry Biotechnology
CEO Mr. Wesley H. Kaupinen
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Palvella Therapeutics, Inc. FAQs
What is the share price of Palvella Therapeutics, Inc. today?
The current share price of Palvella Therapeutics, Inc. is $112.87.
Can I buy Palvella Therapeutics, Inc. shares in India?
Yes, Indian investors can buy Palvella Therapeutics, Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Palvella Therapeutics, Inc. shares in India?
You can easily invest in Palvella Therapeutics, Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Palvella Therapeutics, Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Palvella Therapeutics, Inc..
Can I buy fractional shares of Palvella Therapeutics, Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Palvella Therapeutics, Inc.?
Palvella Therapeutics, Inc. has a market cap of $1600.83 M.
In which sector does Palvella Therapeutics, Inc. belong?
Palvella Therapeutics, Inc. operates in the Biotechnology sector.
What documents are required to invest in Palvella Therapeutics, Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Palvella Therapeutics, Inc.?
The PE ratio of Palvella Therapeutics, Inc. is N/A and the PB ratio is 41.83.